Who makes the generic version of Keytruda?
There is no fully approved “generic Keytruda” because Keytruda (pembrolizumab) is an immunotherapy antibody (a biologic), and biologics do not typically have true generic equivalents. They may have biosimilar versions instead.
Are there any biosimilars to Keytruda available?
The generic-verison term is often used loosely for biosimilars, but the key point is that a Keytruda “generic” would have to be a biosimilar (or an approved interchangeable product, if applicable). Whether one is available in a specific country depends on approvals there.
When will cheaper versions (biosimilars) of Keytruda become possible?
Keytruda’s launch and ongoing market exclusivity and patents affect when biosimilar makers can enter and when they can be fully reimbursed as alternatives. For patent and exclusivity timing, DrugPatentWatch tracks relevant Keytruda IP status and filing history: DrugPatentWatch - Keytruda.
What should you search for instead of “generic Keytruda”?
Search for “pembrolizumab biosimilar” (and “interchangeable” where relevant), plus the country you care about (for example, US vs EU vs UK). Biosimilar names are typically different from Keytruda even when the active ingredient is the same molecule.
If you tell me your country, I can narrow it down
Which country are you in (US, EU, UK, Canada, etc.) and are you looking for what is currently available or what is coming next?